Literature DB >> 26452370

[Acute inpatient multimodal pain therapy and rehabilitation: Framework conditions, tasks and differentiated patient allocation].

B Arnold1, H-R Casser2, K Klimczyk3, J Lutz4, T Brinkschmidt5, I Gralow6, D Irnich7, U Kaiser8, B Nagel2, M Schiltenwolf9, M Pfingsten10, R Sabatowski8, W Söllner11.   

Abstract

Multimodal pain treatment programs are widely accepted as the medical treatment standard in the management of patients with chronic pain syndromes. The concepts and treatment strategies are based on the biopsychosocial model of pain and programs for early restoration of function. Although this concept is primarily implemented in the curative field, i.e. in hospitals for the treatment of patients with chronic pain diseases, modified programs based on the International Classification of Functioning (ICF) can now also be found in rehabilitation clinics. Despite the assumed similarities, significant differences in, for example the aims of the therapy and relevant structural and process variables have to be kept in mind when allocating patients to a program as provided by a hospital or a rehabilitation clinic. The aim of this article is to present the framework structures of both treatment levels with respect to the implementation of multimodal pain therapy programs and to elucidate the differential diagnostic approach to the indications.

Entities:  

Keywords:  Biopsychosocial model; Chronic pain; Germany; Legal aspects; Tertiary care

Mesh:

Year:  2015        PMID: 26452370     DOI: 10.1007/s00482-015-0063-8

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  26 in total

1.  Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials.

Authors:  Winfried Häuser; Kathrin Bernardy; Bernhard Arnold; Martin Offenbächer; Marcus Schiltenwolf
Journal:  Arthritis Rheum       Date:  2009-02-15

Review 2.  [Multidisciplinary assessment for multimodal pain therapy. Indications and range of performance].

Authors:  H-R Casser; B Arnold; T Brinkschmidt; I Gralow; D Irnich; K Klimczyk; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2013-08       Impact factor: 1.107

3.  Comparison of a biopsychosocial therapy (BT) with a conventional biomedical therapy (MT) of subacute low back pain in the first episode of sick leave: a randomized controlled trial.

Authors:  Marcus Schiltenwolf; Matthias Buchner; Bernhard Heindl; Johannes von Reumont; Annette Müller; Wolfgang Eich
Journal:  Eur Spine J       Date:  2005-11-26       Impact factor: 3.134

4.  [Long-term efficiency of orthopedic rehabilitation in chronic back pain--the integrative orthopedic psychosomatic concept (IopKo)].

Authors:  S Dibbelt; B Greitemann; C Büschel
Journal:  Rehabilitation (Stuttg)       Date:  2006-12       Impact factor: 1.113

5.  [From GRIP to multimodal pain therapy. A concept asserts itself].

Authors:  J Hildebrandt; M Pfingsten
Journal:  Orthopade       Date:  2009-10       Impact factor: 1.087

Review 6.  [Multimodal pain therapy for treatment of chronic pain syndrome. Consensus paper of the ad hoc commission on multimodal interdisciplinary pain management of the German Pain Society on treatment contents].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; A Diezemann; I Gralow; D Irnich; U Kaiser; B Klasen; K Klimczyk; J Lutz; B Nagel; M Pfingsten; R Sabatowski; R Schesser; M Schiltenwolf; D Seeger; W Söllner
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

7.  [The Dachau multidisciplinary treatment program for chronic pain. Efficacy data of a diagnosis-independent multidisciplinary treatment program for back pain and other types of chronic pain].

Authors:  K Pöhlmann; T Tonhauser; P Joraschky; B Arnold
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

8.  [Multicomponent therapy for treatment of fibromyalgia syndrome].

Authors:  B Arnold; W Häuser; K Bernardy; W Brückle; E Friedel; V Köllner; H Kühn-Becker; M Richter; M Weigl; T Weiss; M Offenbächer
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 9.  [Multimodal pain therapy: principles and indications].

Authors:  B Arnold; T Brinkschmidt; H-R Casser; I Gralow; D Irnich; K Klimczyk; G Müller; B Nagel; M Pfingsten; M Schiltenwolf; R Sittl; W Söllner
Journal:  Schmerz       Date:  2009-04       Impact factor: 1.107

10.  [Multidisciplinary treatment program for chronic low back pain, part 1. Overview].

Authors:  J Hildebrandt; M Pfingsten; C Franz; P Saur; D Seeger
Journal:  Schmerz       Date:  1996-08-26       Impact factor: 1.107

View more
  5 in total

Review 1.  [Implementation of interdisciplinary multimodal pain therapy according to OPS 8‑918 : Recommendations of the ad hoc commission for interdisciplinary multimodal pain therapy of the German Pain Association].

Authors:  B Arnold; A Böger; T Brinkschmidt; H-R Casser; D Irnich; U Kaiser; K Klimczyk; J Lutz; M Pfingsten; R Sabatowski; M Schiltenwolf; W Söllner
Journal:  Schmerz       Date:  2018-02       Impact factor: 1.107

2.  [Interdisciplinary multimodal pain therapy 2020 : Appropriate structures and performance-related reimbursement].

Authors:  R Thoma
Journal:  Schmerz       Date:  2018-02       Impact factor: 1.107

Review 3.  [Prevention of chronic pain in the German healthcare system : Current state and perspective].

Authors:  Ulrike Kaiser; Bernd Nagel; Frank Petzke; Michael Pfingsten; Anne Gärtner; Thomas Isenberg; Katharina Augustin; Carolin Martin; Gabriele Lindena
Journal:  Schmerz       Date:  2021-01-15       Impact factor: 1.107

Review 4.  [Is interdisciplinary multimodal pain therapy threatened? : Increasing controversy on the necessity for inpatient treatment].

Authors:  J Lutz; J von Sachsen; B Arnold; A Böger; M Pfingsten
Journal:  Schmerz       Date:  2020-04       Impact factor: 1.107

5.  [Evaluation of an early interdisciplinary multimodal assessment for patients with pain : Protocol of a randomized controlled study (PAIN2020)].

Authors:  Ulrike Kaiser; Frank Petzke; Bernd Nagel; Ursula Marschall; Hans-Raimund Casser; Thomas Isenberg; Thomas Kohlmann; Gabriele Lindena
Journal:  Schmerz       Date:  2021-08       Impact factor: 1.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.